NO941770L - Substituert mono- og bipyridylmetylpyridon - Google Patents

Substituert mono- og bipyridylmetylpyridon

Info

Publication number
NO941770L
NO941770L NO941770A NO941770A NO941770L NO 941770 L NO941770 L NO 941770L NO 941770 A NO941770 A NO 941770A NO 941770 A NO941770 A NO 941770A NO 941770 L NO941770 L NO 941770L
Authority
NO
Norway
Prior art keywords
carbon atoms
mono
halogen
formula
substituted
Prior art date
Application number
NO941770A
Other languages
English (en)
Norwegian (no)
Other versions
NO941770D0 (no
Inventor
Peter Fey
Walter Hubsch
Jurgen Dressel
Rudolf Hanko
Thomas Kramer
Ulrich E Muller
Mattias Muller-Gliemann
Martin Beuck
Hilmar Bischoff
Stefan Wohlfeil
Dirk Denzer
Stanislav Kazda
Johannes-Peter Stasch
Andreas Knorr
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO941770D0 publication Critical patent/NO941770D0/no
Publication of NO941770L publication Critical patent/NO941770L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO941770A 1993-05-13 1994-05-11 Substituert mono- og bipyridylmetylpyridon NO941770L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4316077A DE4316077A1 (de) 1993-05-13 1993-05-13 Substituierte Mono- und Bihydridylmethylpyridone

Publications (2)

Publication Number Publication Date
NO941770D0 NO941770D0 (no) 1994-05-11
NO941770L true NO941770L (no) 1994-11-14

Family

ID=6488035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941770A NO941770L (no) 1993-05-13 1994-05-11 Substituert mono- og bipyridylmetylpyridon

Country Status (21)

Country Link
US (1) US5407948A (enExample)
EP (1) EP0624583B1 (enExample)
JP (1) JPH06329669A (enExample)
CN (1) CN1102648A (enExample)
AT (1) ATE155782T1 (enExample)
AU (1) AU672679B2 (enExample)
CA (1) CA2123243A1 (enExample)
CZ (1) CZ117294A3 (enExample)
DE (2) DE4316077A1 (enExample)
DK (1) DK0624583T3 (enExample)
ES (1) ES2105408T3 (enExample)
FI (1) FI942160L (enExample)
GR (1) GR3024465T3 (enExample)
HU (1) HUT70485A (enExample)
IL (1) IL109604A0 (enExample)
NO (1) NO941770L (enExample)
NZ (1) NZ260490A (enExample)
PH (1) PH30908A (enExample)
SK (1) SK55694A3 (enExample)
TW (1) TW245718B (enExample)
ZA (1) ZA943246B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6417185B1 (en) 1998-06-19 2002-07-09 Chiron Corporation Inhibitors of glycogen synthase kinase 3
AU2002351412B2 (en) 2001-12-21 2010-05-20 Exelixis Patent Company Llc Modulators of LXR
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
ES2334990T3 (es) * 2002-02-14 2010-03-18 Pharmacia Corporation Piridinonas sustituidas como moduladores de p38 map quinasa.
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
ATE528302T1 (de) 2005-08-29 2011-10-15 Vertex Pharma 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
ATE548363T1 (de) * 2005-08-29 2012-03-15 Vertex Pharma 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
DE602006020293D1 (de) * 2005-08-29 2011-04-07 Vertex Pharma 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin-kinasen nützlich sind
TWI417095B (zh) * 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
KR20100080597A (ko) * 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된-４-페닐-1ｈ-피리딘-2-온
CA2696948C (en) * 2007-09-14 2013-04-30 Jose Maria Cid-Nunez 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
EP2220083B1 (en) * 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt) 2008-11-28 2015-12-29 Addex Pharmaceuticals Sa derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
NZ596078A (en) 2009-05-12 2013-06-28 Janssen Pharmaceuticals Inc 1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
EA020671B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
ES2782999T3 (es) * 2009-11-06 2020-09-16 Aerpio Therapeutics Inc Composiciones y métodos para tratar la colitis
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Ｇｐｒ８４アンタゴニストおよびその使用
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100917A0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
US5155117A (en) * 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
EP0624583B1 (de) 1997-07-23
NO941770D0 (no) 1994-05-11
CN1102648A (zh) 1995-05-17
AU672679B2 (en) 1996-10-10
CZ117294A3 (en) 1994-11-16
CA2123243A1 (en) 1994-11-14
PH30908A (en) 1997-12-23
ATE155782T1 (de) 1997-08-15
IL109604A0 (en) 1994-08-26
SK55694A3 (en) 1995-02-08
FI942160A7 (fi) 1994-11-14
FI942160A0 (fi) 1994-05-10
GR3024465T3 (en) 1997-11-28
ES2105408T3 (es) 1997-10-16
HU9401417D0 (en) 1994-08-29
ZA943246B (en) 1995-01-18
DE59403427D1 (de) 1997-08-28
AU6056194A (en) 1994-11-17
DE4316077A1 (de) 1994-11-17
FI942160L (fi) 1994-11-14
JPH06329669A (ja) 1994-11-29
HUT70485A (en) 1995-10-30
US5407948A (en) 1995-04-18
NZ260490A (en) 1995-12-21
DK0624583T3 (da) 1998-03-02
EP0624583A1 (de) 1994-11-17
TW245718B (enExample) 1995-04-21

Similar Documents

Publication Publication Date Title
FI942160A0 (fi) Substituoituja mono- ja bipyridyylimetyylipyridoneja
NO970174L (no) 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner
GEP19981488B (en) Dihalotriazolopyrimidine Derivatives,Method for Its Production, Fungicidal Composition on Its Basis and Their Use as Fungicides
PT1069124E (pt) Compostos 2-benzimidazolilamina como agonistas dos receptores
WO2006113615A3 (en) Anti-microbial agents and uses thereof
DE69722027D1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
WO2005007625A3 (en) Heterocyclic amides with anti-tuberculosis activity
WO2003059907A1 (en) Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
TW200602315A (en) Substituted pyrazinecarboxanilide derivatives or salts thereof, intermediates thereof, agrohorticultural agents, and method for use the same
NO844291L (no) Griseolsyrederivater
IL146968A0 (en) Benzamide derivatives, insecticides fro agricultural and horticultural use and usage thereof
NO964525D0 (no) O-Acyl-4-fenyl-cykloheksanoler, deres salter, legemidler som inneholder disse forbindelser og deres anvendelse, samt fremgangsmåter for fremstilling av dem
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
DE69203426D1 (de) Oximderivate von Formylpyridylimidazolinone, deren herbizide Verwendung und Verfahren zu deren Herstellung.
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
ATE43140T1 (de) Derivate von enzym-hemmender griseolsaeure und deren verwendung.
EP1211253A4 (en) DIHYDROBENZOFURAN TRICYCLIC DERIVATIVES, THEIR PREPARATION METHOD AND AGENTS
GR3002560T3 (en) 2-selenomethyl-1, 4-dihydropyridines, a process for the preparation thereof and pharmaceutical compositions containing them
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
NO941519L (no) 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler
DK1246824T3 (da) Diazepin-carboxamid-derivater, deres fremstilling, deres anvendelse som medikamenter, farmaceutiske præparater og deres anvendelse